Mar 3, 2020
Patricia Zilliox could have chosen any city as U.S. headquarters for her French biotech startup Eyevensys, which recently raised $30 million to develop eye disease treatments. She chose Fort Worth. That’s because Alcon and the North Texas Eye Research Institute at HSC have turned Cowtown into a world-renowned hotbed of eye research innovation.
Learn more:
North Texas Eye Research Institute
The (Alcon) Family Tree: How One Company Seeded a DFW Life Science Legacy